| Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012 B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri, I Kalsekar, ... BMJ Open Diabetes Research and Care 4 (1), e000154, 2016 | 195 | 2016 |
| Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone MG de Verdier, M Andersson, DM Kern, S Zhou, O Tunceli Value in Health 18 (6), 759-766, 2015 | 68 | 2015 |
| Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States DM Kern, S Zhou, S Chavoshi, O Tunceli, M Sostek, J Singer, ... Am J Manag Care 21 (3), e222-e234, 2015 | 56 | 2015 |
| Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a … MH Kyaw, DM Kern, S Zhou, O Tunceli, HS Jafri, J Falloon BMC health services research 15, 1-11, 2015 | 45 | 2015 |
| Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods O Tunceli, R Wade, T Gu, JR Bouchard, M Aagren, W Luo Current medical research and opinion 26 (8), 1827-1834, 2010 | 42 | 2010 |
| The use of migraine preventive medications among patients with and without migraine headaches JE Lafata, O Tunceli, M Cerghet, KP Sharma, RB Lipton Cephalalgia 30 (1), 97-104, 2010 | 41 | 2010 |
| Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller … DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... Respiratory research 16, 1-12, 2015 | 40 | 2015 |
| Cancer survivorship, health insurance, and employment transitions among older workers K Tunceli, PF Short, JR Moran, O Tunceli INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2009 | 39 | 2009 |
| Impact of nonadherence to inhaled corticosteroid/LABA therapy on COPD exacerbation rates and healthcare costs in a commercially insured US population JR Davis, B Wu, DM Kern, O Tunceli, KM Fox, J Horton, RF Legg, F Trudo American health & drug benefits 10 (2), 92, 2017 | 37 | 2017 |
| Applying weighting methodologies to a commercial database to project US Census demographic data T Wasser, B Wu, WY Joseph, O Tunceli MJH Life Sciences, 2015 | 34 | 2015 |
| Assessment of outpatient and inpatient antibiotic treatment patterns and health care costs of patients with complicated urinary tract infections RM Turner, B Wu, K Lawrence, J Hackett, S Karve, O Tunceli Clinical therapeutics 37 (9), 2037-2047, 2015 | 33 | 2015 |
| Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... International journal of chronic obstructive pulmonary disease, 1417-1425, 2015 | 32 | 2015 |
| Initiation patterns of statins in the 2 years after release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol management guideline in … T Olufade, S Zhou, D Anzalone, DM Kern, O Tunceli, MJ Cziraky, ... Journal of the American Heart Association 6 (5), e005205, 2017 | 29 | 2017 |
| Increased burden of healthcare utilization and cost associated with opioid-related constipation among patients with noncancer pain AW Fernandes, DM Kern, C Datto, YW Chen, C McLeskey, O Tunceli American Health & Drug Benefits 9 (3), 160, 2016 | 29 | 2016 |
| Estimating the real-world cost of diabetes mellitus in the United States during an 8-year period using 2 cost methodologies VJ Willey, S Kong, B Wu, A Raval, T Hobbs, A Windsheimer, ... American Health & Drug Benefits 11 (6), 310, 2018 | 28 | 2018 |
| Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population DM Kern, C Mellström, PR Hunt, O Tunceli, B Wu, M Westergaard, ... Current medical research and opinion 32 (4), 703-711, 2016 | 26 | 2016 |
| Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments F Trudo, DM Kern, JR Davis, O Tunceli, S Zhou, EL Graham, C Strange, ... International journal of chronic obstructive pulmonary disease, 2055-2066, 2015 | 26 | 2015 |
| Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis O Tunceli, SA Williams, DM Kern, H Elhefni, N Pethick, C Wessman, ... The Journal of Allergy and Clinical Immunology: In Practice 2 (6), 719-726. e6, 2014 | 23 | 2014 |
| Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007-2012. BMJ Open Diabetes Res Care 2016; 4: e000154 B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri Epub 2016/04/26, 2016 | 15 | 2016 |
| Health care utilization and costs after initiating budesonide/formoterol combination or fluticasone/salmeterol combination among COPD patients new to ICS/LABA treatment JR Davis, DM Kern, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... Journal of Managed Care & Specialty Pharmacy 22 (3), 293-304, 2016 | 14 | 2016 |
